MARLBOROUGH, Mass.--(BUSINESS WIRE)--
Hologic, Inc. (Nasdaq: HOLX) announced today that a Massachusetts
Superior Court granted a preliminary injunction in lawsuits against
Chinese X-ray equipment provider Direct Digital Imaging Technology
(Beijing), Inc. (DDIT) and a former Hologic employee, Lawrence Ibbetson,
for alleged misappropriation of trade secrets.
Hologic alleges that DDIT and Ibbetson misappropriated trade secrets for
selenium coating technology used in the detectors within Hologic's
Selenia® Dimensions® and 3Dimensions™
mammography systems. In 2016, Hologic filed suit against DDIT, alleging
breach of contract for failure to pay for general radiography panels
treated with Hologic’s proprietary coatings. In 2018, the complaint was
amended to include trade secret misappropriation claims.
As part of the preliminary injunction, the Court ruled that Hologic is
likely to succeed in its trade secret claims. As a result, the Court
ordered the defendants to stop using or disclosing selenium coating
specifications that Hologic alleges were wrongfully misappropriated. In
addition, the defendants may not develop an alternative selenium coating
unless certain conditions are met, including that the development be
conducted under the watch of an independent monitor. The preliminary
injunction is effective through the conclusion of a trial.
“We are very pleased with the Superior Court’s ruling," said Pete
Valenti, President of Breast and Skeletal Health at Hologic. "As the
world leader and innovator in mammography, we will continue to defend
our intellectual property against what we believe to be unfair trade
practices in order to protect the innovations that drive advances for
our customers and outcomes for their patients.”
About Hologic, Inc.
Hologic, Inc. is an innovative medical technology company primarily
focused on improving women's health and well-being through early
detection and treatment. For more information on Hologic, visit www.hologic.com.
Hologic, 3D, 3Dimensions, Dimensions, Selenia, The Science of Sure, and
associated logos are trademarks and/or registered trademarks of Hologic,
Inc. and/or its subsidiaries in the United States and/or other countries.
Forward-Looking Statements
This news release may contain forward-looking information that involves
risks and uncertainties, including statements about the likelihood of
Hologic succeeding in its trade secret claims. There can be no assurance
that Hologic will prevail at trial or in any appeal. Hologic expressly
disclaims any obligation or undertaking to release publicly any updates
or revisions to any such statements presented herein to reflect any
change in expectations or any change in events, conditions or
circumstances on which any such data or statements are based.
SOURCE: Hologic, Inc.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20181212005132/en/
Media Contact:
Jane Mazur
508.263.8764 (direct)
585.355.5978
(mobile)
jane.mazur@hologic.com
Investor Contact:
Michael Watts
858.410.8588
Michael.watts@hologic.com
Source: Hologic, Inc.